PubRank

Anissa Abi-Dargham

Author PubWeight™ 71.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003 3.21
2 Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005 2.45
3 The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012 2.34
4 Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 2010 2.19
5 Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 2003 1.92
6 Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2012 1.91
7 Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 2005 1.52
8 In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride. Synapse 2004 1.46
9 Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007 1.44
10 Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone. J Psychopharmacol 2010 1.43
11 Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. J Nucl Med 2004 1.35
12 Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride. Biol Psychiatry 2010 1.33
13 Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. J Nucl Med 2006 1.24
14 Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005 1.22
15 Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 2008 1.22
16 Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep 2007 1.21
17 Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 2007 1.21
18 Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology 2009 1.15
19 Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride. Synapse 2010 1.15
20 Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 2005 1.12
21 Cognitive and brain function in schizotypal personality disorder. Schizophr Res 2002 1.10
22 Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull 2009 1.10
23 Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clin N Am 2007 1.09
24 Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 2006 1.05
25 Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry 2012 1.03
26 Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology 2009 1.02
27 The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 2006 1.00
28 In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 2007 1.00
29 Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge. Biol Psychiatry 2011 0.99
30 In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO. Neuropsychopharmacology 2010 0.98
31 Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography. Biol Psychiatry 2010 0.97
32 Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907. Neuropsychopharmacology 2012 0.97
33 Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biol Psychiatry 2003 0.96
34 Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 2008 0.96
35 Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia. Neuropsychopharmacology 2003 0.95
36 Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder. Depress Anxiety 2009 0.95
37 Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Synapse 2005 0.95
38 Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction? Biochem Pharmacol 2011 0.94
39 Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 2005 0.94
40 The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. Handb Exp Pharmacol 2012 0.93
41 Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging. Psychopharmacology (Berl) 2011 0.93
42 Striatal dopamine in bulimia nervosa: a PET imaging study. Int J Eat Disord 2012 0.92
43 Presynaptic dopamine in schizophrenia. CNS Neurosci Ther 2010 0.91
44 Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. Am J Psychiatry 2005 0.91
45 Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 2010 0.89
46 Safety of radial arterial catheterization in PET research subjects. J Nucl Med 2009 0.89
47 Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone. Neuroimage 2011 0.88
48 [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 2007 0.87
49 Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence. Biol Psychiatry 2008 0.87
50 Dynamic shifts in brain network activation during supracapacity working memory task performance. Hum Brain Mapp 2014 0.87
51 The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Res 2011 0.85
52 Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112. Psychopharmacology (Berl) 2014 0.84
53 Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry 2005 0.83
54 Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635. Psychopharmacology (Berl) 2006 0.83
55 Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology (Berl) 2005 0.82
56 Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652. Psychopharmacology (Berl) 2002 0.82
57 Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis. Synapse 2011 0.81
58 Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride. J Cereb Blood Flow Metab 2010 0.80
59 Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Biol Psychiatry 2011 0.80
60 In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 2013 0.79
61 How have developments in molecular imaging techniques furthered schizophrenia research? Imaging Med 2009 0.77
62 Positron emission tomography and single photon emission CT molecular imaging in schizophrenia. Neuroimaging Clin N Am 2003 0.76
63 An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M 1) positive allosteric modulator in the living human brain using positron emission tomography. EJNMMI Res 2014 0.76
64 Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms. Psychopharmacology (Berl) 2002 0.76
65 Integrating the neurobiology of schizophrenia. Preface. Int Rev Neurobiol 2007 0.75
66 Neurochemical imaging in schizophrenia. Curr Top Behav Neurosci 2010 0.75
67 Imaging drug action in schizophrenia: research update. Eur Psychiatry 2003 0.75